Dugan Margaret 4
4 · Schrodinger, Inc. · Filed Aug 10, 2023
Insider Transaction Report
Form 4
Dugan Margaret
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-08-09+90,000→ 90,000 totalExercise: $39.89Exp: 2033-08-09→ Common Stock (90,000 underlying) - Award
Common Stock
2023-08-09+15,000→ 15,000 total
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2021 Inducement Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on August 9, 2023 and will vest in equal installments on each of October 15, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.
- [F2]Includes 15,000 unvested RSUs.
- [F3]The option was granted on August 9, 2023 under the Issuer's 2021 Inducement Equity Incentive Plan. The shares underlying the option are scheduled to vest with respect to 25% of the shares on July 31, 2024 and the remainder are scheduled to vest in equal monthly installments through July 31, 2027.